Association of MMP but not TIMP-1 gene polymorphisms with recurrent aphthous stomatitis

J A Karasneh1, M E Bani-Hani, A M Alkhateeb

  • 1Department of Oral Medicine and Oral Surgery, Jordan University of Science and Technology (JUST), Irbid, Jordan.

Oral Diseases
|October 15, 2013
PubMed
Abstract

Insights

Genetic variations in MMP-9 are linked to recurrent aphthous stomatitis (RAS) susceptibility. Specifically, the MMP-9 rs11697325 polymorphism showed a significant association with RAS in the studied population.

Area of Science:

  • Genetics and Oral Medicine
  • Inflammatory Disease Research

Background:

  • Recurrent aphthous stomatitis (RAS) is a prevalent oral inflammatory condition influenced by genetic and environmental factors.
  • Gelatinases (MMP-2, MMP-9) and their inhibitor (TIMP-1) play roles in inflammation.

Purpose of the Study:

  • To investigate the association between specific gene polymorphisms in MMP-2, MMP-9, and TIMP-1 and the susceptibility to RAS.
  • To identify potential genetic markers for RAS risk.

Main Methods:

  • Genotyping of five polymorphisms: rs17576, rs3918242, rs11697325 (MMP-9), rs2285053 (MMP-2), and rs6609533 (TIMP-1).
  • Study included 96 RAS patients and 153 healthy controls.
  • Association analysis using logistic regression and linkage disequilibrium (LD) assessment.

Main Results:

  • A significant association was found between MMP-9 rs11697325 and RAS (OR=3.1, P=0.009).
  • The AA genotype of MMP-9 rs11697325 was more frequent in RAS patients.
  • Strong LD between MMP-9 rs11697325 and rs17576 was observed, with altered haplotype frequencies in patients.

Conclusions:

  • This study provides the first evidence linking MMP-9 gene polymorphisms to RAS susceptibility.
  • The MMP-9 rs11697325 polymorphism is significantly associated with RAS.
  • Further research, including functional studies and replication in diverse populations, is warranted.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.9K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.9K